Gene therapy has transformed treatment for diseases like sickle cell and leukemia, but the methods used to deliver it can still carry risks. Researchers from U-M Engineering and Michigan Medicine are developing a new, non-viral approach to safely deliver genetic material into human cells, with early tests showing promise across multiple cell types.
